Skip to Main Content

Author Details

Takahito Fukusumi
Osaka University Graduate School of Medicine
2012
51
18
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36787504Clearance Profile of Circulating Tumor Human Papillomavirus DNA During Radiotherapy Predicts Clinical Outcomes in Human Papillomavirus-Related Oropharyngeal Cancer.JCO Precis Oncol2023
38022262Microscopic Residual Disease After Nasal Squamous Cell Carcinoma Not Visualized on FDG PET-CT: A Case Report.Cureus2023
38059478Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.Acta Otolaryngol2023
37272954Activated fibroblasts in muscle sarcoidosis revealed by [<sup>18</sup>F]FAPI-74 PET.Eur J Nucl Med Mol Imaging2023
34486724Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.Int J Cancer2022
32895945Circulating tumor HPV DNA complements PET-CT in guiding management after radiotherapy in HPV-related squamous cell carcinoma of the head and neck.Int J Cancer2021
33491747Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma.Int J Oncol2021
33813412Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer.Anticancer Res2021
34366245Corrigendum to "Prevalence of human papillomavirus in oral gargles and tonsillar washings" [Oral Oncol. 105 (2020) 104669].Oral Oncol2021
33373656Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.Int J Radiat Oncol Biol Phys2021
33368784Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma.Head Neck2021
32259682Prevalence of human papillomavirus in oral gargles and tonsillar washings.Oral Oncol2020
31721164A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.Cancer2020
31850594Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.Head Neck2020
32848210HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.Oncogene2020
30933315Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.Cancer2019
31444114Successful control of T4 and N3 human papillomavirus-related oropharyngeal squamous cell carcinoma after de-intensified chemoradiotherapy: Report of two cases.Oral Oncol2019
31097695Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.Nat Commun2019
31142745Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.Nat Commun2019
31109690Metabolic tumor volume of metastatic lymph nodes and survival after total laryngectomy in laryngeal and hypopharyngeal cancer.Oral Oncol2019
29146722The <i>NOTCH4</i>-<i>HEY1</i> Pathway Induces Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.Clin Cancer Res2018
29945995Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.Clin Cancer Res2018
30070359Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.Int J Cancer2018
29489439The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.J Dent Res2018
28084858Age-adjusted Charlson comorbidity index as a prognostic factor of hypopharyngeal cancer treated with chemoradiation therapy.Acta Otolaryngol2017
27166395Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity.Clin Cancer Res2016
27732629Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer.PLoS One2016
24890618Prognostic significance of body mass index before treatment for head and neck cancer.Head Neck2015
26330103Cancer stem cells: The potential of carbon ion beam radiation and new radiosensitizers (Review).Oncol Rep2015
26115903Factors predicting severe infections during chemotherapy in head and neck cancer patients.Acta Otolaryngol2015
26137071Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26.Oncol Lett2015
25622661Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.Acta Otolaryngol2015
25586680Mathematical analysis predicts imbalanced IDH1/2 expression associates with 2-HG-inactivating β-oxygenation pathway in colorectal cancer.Int J Oncol2015
24378718Novel drug discovery system for cancer stem cells in human squamous cell carcinoma of the esophagus.Oncol Rep2014
25269626Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity.Int J Oncol2014
25269542Visualization and characterization of cancer stem-like cells in cervical cancer.Int J Oncol2014
25131392Factors associated with malnutrition in patients with head and neck cancer.Acta Otolaryngol2014
24874475CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma.Br J Cancer2014
24317739Cells of origin of squamous epithelium, dysplasia and cancer in the head and neck region after bone marrow transplantation.Int J Oncol2014
23354547Depletion of JARID1B induces cellular senescence in human colorectal cancer.Int J Oncol2013
24649241Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth.Mol Clin Oncol2013
24649116Eradication of therapy-resistant cancer cells in gastrointestinal organs.Mol Clin Oncol2013
23848007[Cancer stem cells depend on their own niche].Gan To Kagaku Ryoho2013
23452121Adipose-derived mesenchymal stem cells and regenerative medicine.Dev Growth Differ2013
23440340Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.Int J Oncol2013
22151786Reprogramming of gastrointestinal cancer cells.Cancer Sci2012
22293932Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.Int J Oncol2012
22446887Dicer 1, ribonuclease type III modulates a reprogramming effect in colorectal cancer cells.Int J Mol Med2012
22735680Transcriptomic study of dormant gastrointestinal cancer stem cells.Int J Oncol2012
23060915microRNA-based cancer cell reprogramming technology.Exp Ther Med2012
  • 1 - 50 of 51

Recommended Authors

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 0
University of California san francisco
Career Start Year 2013
Number of shared co-authors 1
University Hospital Wurzburg
Career Start Year 2013
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2010
Number of shared co-authors 0
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 12
Cumming School of Medicine, University of Calgary
Career Start Year 2008
Number of shared co-authors 0
George Washington University
Career Start Year 2007
Number of shared co-authors 6
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
University of Colorado Denver
Career Start Year 2006
Number of shared co-authors 1
Cornell University
Career Start Year 2005
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Jewish General Hospital
Career Start Year 2004
Number of shared co-authors 0
Research Institute, Princess Margaret Cancer Centre
Career Start Year 2002
Number of shared co-authors 0
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 13
University of Western Ontario
Career Start Year 2001
Number of shared co-authors 0
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 7
University of Chicago Medicine
Career Start Year 1999
Number of shared co-authors 0
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 3
Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 8
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 13
University of California san francisco
Career Start Year 1988
Number of shared co-authors 11
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 2
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 1
Vrije Universiteit Amsterdam
Career Start Year 1986
Number of shared co-authors 1

Collaborators

University of California
Co-authored papers 11
Beijing Friendship Hospital, Capital Medical University
Co-authored papers 10
University of Tokyo
Co-authored papers 10
Tokai University
Co-authored papers 10
Moores Cancer Center, University of California
Co-authored papers 9
Xiangya Hospital, Central South University
Co-authored papers 9
Center for Computational Biology and Bioinformatics, University of California
Co-authored papers 6
Moores Cancer Center, University of California San Diego
Co-authored papers 6
Niigata Prefectural Tokamachi Hospital.
Co-authored papers 6
Chinese University of Hong Kong
Co-authored papers 6
Moores Cancer Center, University of California
Co-authored papers 6
Johns Hopkins School of Medicine
Co-authored papers 5
University of Washington
Co-authored papers 4
Johns Hopkins University School of Medicine
Co-authored papers 4
University of Texas at Houston Health Science Center
Co-authored papers 4
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers 4
University of California San Diego
Co-authored papers 3
University of California San Diego
Co-authored papers 3
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Johns Hopkins University School of Medicine
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of California
Co-authored papers 2
The University of Tokyo
Co-authored papers 2
Herbert Wertheim School of Public Health, University of California San Diego
Co-authored papers 2
University of California San Diego Health Moores Cancer Center.
Co-authored papers 2
University of California San Diego
Co-authored papers 1
University of Michigan Medical School.
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Moores Cancer Center, University of California San Diego
Co-authored papers 1
University of California
Co-authored papers 1